Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Device Finds Stray Cancer Cells in Patients’ Blood

Published: Wednesday, April 10, 2013
Last Updated: Wednesday, April 10, 2013
Bookmark and Share
A microfluidic device that captures circulating tumor cells could give doctors a noninvasive way to diagnose and track cancers.

Doctors typically diagnose cancer via a biopsy, which can be invasive and expensive. A better way to diagnose the disease would be to detect telltale tumor cells floating in the bloodstream, but such a test has proved difficult to develop because stray cancer cells are rare, and it’s difficult to separate them from the mélange of cells in circulation.

Now researchers from Massachusetts General Hospital and Harvard Medical School say they’ve built a microfluidic device that can quickly grab nearly any type of tumor cell, an advance that may one day lead to simple blood tests for detecting or tracking cancer.

Similar, existing devices—including earlier versions developed by the authors of the study in Wednesday’s online issue of Science Translational Medicine—depend on tumor-specific biomarkers on the surface of the cells to pull them out of a blood sample, meaning that a given device won’t work for all cancer types. What’s more, the efficiency by which the tumor cells are purified from other cell types is generally low and time-consuming. In a given blood sample, circulating tumor cells are rare—there may be only one tumor cell for every billion cells.

The new device is a “substantial step forward from previous microfluidic devices,” says Peter Kuhn, a circulating-tumor-cell researcher at the Scripps Research Institute. Kuhn was not involved in the study. The device combines existing microfluidic techniques of cell sorting into a single device, he says. The result is that the tumor cells can be pulled out of a blood sample quicker, and without prior knowledge of their molecular characteristics.

Mehmet Toner, director of the BioMicroElectroMechanical Systems Resource Center at MGH, and colleagues report that their latest chip can isolate circulating-tumor cells in the blood, and could apply to all types of cancer. “For our earlier chip, you needed to know something on the surface of the tumor cells,” says Toner. In those devices, a small sample of blood would flow through microfluidic chambers, some of which contained an antibody that grabbed tumor cells. That system also took four to five hours to process a single blood sample. “But for early detection and to make this useful for virtually all cancers, we needed to increase the throughput and to make it [tumor-type] independent,” he says.

Identifying these wandering tumor cells could also help researchers study a cancer’s progression and help doctors track treatments or screen for new cases. By studying the surface proteins or genetic profiles of the cancer cells, doctors and researchers could learn which mutations are present in the cancer and perhaps tailor molecularly targeted treatments accordingly. The authors show that 15 tumor cells were recovered from a blood sample from a prostate cancer patient. The gene expression levels of each cell were studied individually and a mix of mutations was found.

The device developed by Toner’s group combines magnetic labeling of cells and microfluidic sorting to process a sample of blood in about an hour or two. To capture tumor cells regardless of their cancer type, the system first tags white blood cells with magnetic beads that are covered with antibodies that recognize proteins on the surface of the immune cells. The sample is then passed into microfluidic chambers that clear out red blood cells, plasma, and unused free magnetic beads based on their size. Then the device discards the tagged white blood cells using a magnetic field. “In the past, we were focused on tumor cells that we know very little about,” says Toner. “Here, we throw away the cells we know everything about, the blood cells,” he says.

The advantage of the new cell-sorting device over previous attempts is that it successfully brings together multiple technologies, such as size separation and magnetic-tag separation, already used in the field, says Gajus Worthington, president and CEO of Fluidigm, a California company that produces microfluidic devices for biomedical research. “The key thing here is the integration, which is crucial to anything related to single-cell work,” he says. All the steps in Toner’s device take place in similar volumes. “If you have to go from one microstep back to macrostep back to microstep, there are losses and complexity, which leads to noise,” says Worthington.

Toner notes that the Holy Grail for circulating-tumor-cell technology would be to diagnose patients early. “About 10 percent of cancer patients survive if they are diagnosed late, but almost 90 percent survive if they are diagnosed early,” says Toner. But whether or not these circulating tumor cells can be found in early-stage patients is not yet clear, says Luis Diaz, an oncologist at Johns Hopkins University School of Medicine. Diaz was not involved in the study. “Early-stage cancers might release very few cells into circulation,” he says. “That’s historically the problem with circulating tumor cells; you can only find them in advanced cancers.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Viruses Join Fight Against Harmful Bacteria
Engineered viruses could combat human disease and improve food safety.
Friday, September 25, 2015
Targeting DNA
Protein-based sensor could detect viral infection or kill cancer cells.
Tuesday, September 22, 2015
Targeting DNA
Protein-based sensor could detect viral infection or kill cancer cells.
Tuesday, September 22, 2015
Searching Big Data Faster
Theoretical analysis could expand applications of accelerated searching in biology, other fields.
Thursday, August 27, 2015
A Metabolic Master Switch Underlying Human Obesity
Researchers find pathway that controls metabolism by prompting fat cells to store or burn fat.
Friday, August 21, 2015
Identifying a Key Growth Factor in Cell Proliferation
Researchers discover that aspartate is a limiter of cell proliferation.
Friday, July 31, 2015
Firms “Under-invest” in Long-Term Cancer Research
Tweaks to the R&D pipeline could create new drugs and greater social benefit.
Thursday, July 30, 2015
Nanoparticles Can Clean Up Environmental Pollutants
Researchers have found that nanomaterials and UV light can “trap” chemicals for easy removal from soil and water.
Thursday, July 23, 2015
Researchers Develop Genetic Tools to Engineer Common Gut Bacterium
Researchers from the Massachusetts Institute of Technology have developed genetic parts that can be combined to program the commensal gut bacterium Bacteroides thetaiotaomicron.
Friday, July 10, 2015
Longstanding Problem Put to Rest
Proof that a 40-year-old algorithm for comparing genomes is the best possible will come as a relief to computer scientists.
Thursday, June 11, 2015
Diagnosing Cancer with Help from Bacteria
Engineered probiotics can detect tumors in the liver.
Friday, May 29, 2015
Master Gene Regulator Could Be New Target For Schizophrenia Treatment
Researchers at MIT’s Picower Institute for Learning and Memory have identified a master genetic regulator that could account for faulty brain functions that contribute to schizophrenia.
Wednesday, May 27, 2015
Brain Tumor Weakness Identified
Discovery could offer a new target for treatment of glioblastoma.
Thursday, April 09, 2015
New Nanodevice Defeats Drug Resistance
Tiny particles embedded in gel can turn off drug-resistance genes, then release cancer drugs.
Wednesday, March 04, 2015
New Nanodevice Defeats Drug Resistance
Tiny particles embedded in gel can turn off drug-resistance genes, then release cancer drugs.
Tuesday, March 03, 2015
Scientific News
Chromosomal Chaos
Penn study forms basis for future precision medicine approaches for Sezary syndrome
Shaking Up the Foundations of Epigenetics
Researchers at the Centre for Genomic Regulation (CRG) and the University of Barcelona (UB) published a study that challenges some of the current beliefs about epigenetics.
Genetic Defences of Bacteria Don’t Aid Antibiotic Resistance
Genetic responses to the stresses caused by antibiotics don’t help bacteria to evolve a resistance to the medications, according to a new study by Oxford University researchers.
Tolerant Immune System Increases Cancer Risk
Researchers have found that individuals with high immunoCRIT ratios may have an increased risk of developing certain cancers.
Developing a Gel that Mimics Human Breast for Cancer Research
Scientists at the Universities of Manchester and Nottingham have been funded to develop a gel that will match many of the biological structures of human breast tissue, to advance cancer research and reduce animal testing.
Lung Repair and Regeneration Gene Discovered
New role for hedgehog gene offers better understanding of lung disease.
3 Ways Viruses Have Changed Science for the Better
Viruses are really good at what they do, and we’ve been able to harness their skills to learn about – and potentially improve – human health in several ways.
Mixed Up Cell Transportation Key Piece of ALS and Dementia Puzzle
Researchers from the University of Toronto are one step closer to solving this incredibly complex puzzle, offering hope for treatment.
New Gene Therapy for Vision Loss From a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
Five New Genetic Variants Linked to Brain Cancer Identified
The biggest ever study of DNA from people with glioma – the most common form of brain cancer – has discovered five new genetic variants associated with the disease.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos